On 20 December 2017, the Italian Competition Authority (or “ICA”) issued a rare infringement decision in an abuse of dominance investigation against the publisher of a local daily newspaper (“SIE”), which refused to deal with a player (the “complainant” or “Euregio”) in the downstream local market for daily media intelligence services. SIE publishes L’Adige, a… continued
Articles from category “Regulatory, Antitrust”
This material was first published by Thomson Reuters as Enzo Marasà, “Italy introduces a legislative ban on price-parity clauses in the booking sector”, (2018) 39(4) E.C.L.R. 196 and is reproduced by agreement with the Publishers. Download the full article by clicking here.
On November 29th, 2017 the European Commission (the “Commission”) has published a Communication (the “Communication”) setting out the EU approach to Standard Essential Patents (or “SEPs”). With the Communication, the Commission offers a numbers of measures and sets out some key principles in order to promote a balanced, clear and predictable framework for the issuance… continued
AGCOM orders Vivendi to comply with a statutory ban to simultaneously hold qualified minority stakes in Telecom and Mediaset
This article was first published on IRIS newsletter – June issue, Italy section On 18 April 2017, the Autorità per le Garanzie nelle Comunicazioni (the Italian Communications Authority – AGCOM) issued a decision by which – for the first time ever – it has applied the ban set forth in Article 43, paragraph 11, of the… continued
This article was first published on Law360 on May 15th, 2017. Download the full PDF here. PART I U.S.-based manufacturers of branded goods who wish to distribute them across the EU may face compelling legal challenges in protecting their ability to tightly select and control their distribution networks, particularly with regards to online sales. Likewise, U.S.-based retailers of… continued
Reproduced with permission from Law Business Research Ltd. Getting the Deal Through: Pharmaceutical Antitrust 2017, (published in April 2017; contributing editors: Marta Giner Asins and Yann Anselin, Norton Rose Fulbright LLP). For further information please visit https://gettingthedealthrough.com/area/26/pharmaceutical-antitrust/. PHARMACEUTICAL REGULATORY LAW 1. Which legislation sets out the regulatory framework for the marketing, authorisation and pricing of… continued